Notes on National Debt, HHS Transformation, and Healthcare Priorities
National Debt and Fiscal Path
- The national debt is a significant threat, exacerbated by the current administration's spending.
- The U.S. is on an unsustainable fiscal path, with a gross national debt of 36,200,000,000,000, equating to over 270,000 per household.
- Addressing waste, fraud, and abuse is crucial to mitigate the debt crisis, especially concerning healthcare costs and an aging population.
- The approach of simply throwing money at the problem has been ineffective.
- The proposed reorganization aims to make the Department of Health and Human Services (HHS) more efficient and effective.
- Cuts are designed to eliminate waste, fraud, abuse, and redundancies to streamline the department.
Decline in American Health
- During the Biden administration, the budget of HHS increased by 38%, but American health declined.
- In 1986, the equivalent of 250 (in current dollars) was spent by the agency; today, 1,450,000,000,000 is spent on chronic disease alone, with the agency's total budget being over 1,700,000,000,000.
- Lifespan ranking has declined from 11th in 1986 to 49th today, indicating that the U.S. is currently the sickest country in the world.
- The U.S. had the highest death rate during COVID-19 due to a high chronic disease burden.
- The focus needs to shift from a sick care system to a health care system.
Realigning HHS and NIH
- Few NIH studies focused on the impact of factors like seed oils, corn syrup, food dyes, packaging, microplastics, and pesticides on children's health; these areas need more attention.
- Examples of studies that were cut include:
- A 2,200,000 study from Boston University on the effects of exogenous testosterone therapy on communication in gender-diverse speakers.
- A 3,000,000 study at the University of Pennsylvania on anti-vaping social media campaigns targeting sexual gender minorities teens between 13 and 18.
- A 1,000,000 study from the University of Michigan on sexual fluidity and longitudinal changes in alcohol misuse.
- The aim is to return NIH to evidence-based science, with gold standard replicated studies, published data, and peer reviews that have been missing for the last 30 years.
Rare Diseases and Orphan Drugs
- Questions will be submitted regarding help for children with ultra-rare mitochondrial disorders, such as HOPE with MLS syndrome and Jackson with Barth syndrome, who need access to lifesaving medications.
- Commitment to helping with orphan drugs and rare diseases.
Prior Approvals
- Acknowledgment of action taken related to prior approvals.